Welcome to the Australian Clinical Trial California Roadshow Directory

Exploring New Models of Global Clinical Trial Collaboration

Search, discover, and book meetings with the Australian clinical trial attendees of the 2026 Australian Clinical Trials California Roadshow. 

Once you have found a potential partner, use this link to book a meeting https://outlook.office.com/book/[email protected]/  
All available meeting times will be shown. If no times are available there will be networking time and many companies will have multiple representatives.

11 Results found

Top Professional services in Australian Clinical Trial California Roadshow Directory

Acclime Australia supports international companies, particularly foreign businesses, looking to establish and scale operations in Australia while accessing the benefits of the Australian Research & Development Tax Incentive program (R&DTI).Our team of corporate, tax, and R&D specialists assists international companies across a broad range of industries to enter the Australian market efficiently and compliantly, while taking advantage of generous benefits for innovation and technology development.Our services include:Market entry and corporate structuring advisory - Assisting companies in selecting the most appropriate structure for their Australian operations, including subsidiary incorporation, branch registration, and cross-border tax considerations.Australian company establishment and registrations – Managing the setup of Australian entities, tax registrations, and Australian bank account support to ensure a smooth market entry process.Resident Director and company officers – Providing experienced Australian/industry-based officers to satisfy local regulatory and tax residency requirements.R&D Tax Incentive advisory - Supporting companies throughout the full R&D lifecycle, including eligibility assessments, technical and financial documentation, application preparation, and ongoing compliance management.Transfer Pricing advisory – Assisting multinational groups with transfer pricing compliance and advisory services to ensure cross-border related party transactions are aligned with Australian tax regulations and transfer pricing principles.Ongoing accounting, tax, payroll, and compliance outsourcing –Enabling international companies to operate in Australia without the need to build a large internal administrative function.Registered office and operational support solutions – Allowing overseas businesses to maintain a compliant local presence while managing operations remotely.With local teams across Australia, the USA, UAE, and the Asia-Pacific region, Acclime combines international business expertise with practical on-the-ground support to help innovative companies confidently expand into Australia and successfully navigate their growth journey.

Focus

R&D Tax Incentive

Working with:

Contact person(s):

Languages: EnglishSpanishFrenchChinese (Simplified)

Year founded: 2011

No of Employees: 1-2,000

Agilex Biolabs is Australia’s largest and FDA-inspected bioanalytical laboratory, with nearly 30 years of experience supporting global pharmaceutical and biotechnology programs. Across our laboratories in Adelaide, Brisbane and Sydney, we provide regulated bioanalytical services spanning LC-MS/MS, immunoassays, flow cytometry, cell-based assays, biomarker testing, PBMC processing and molecular biology.Our facilities feature advanced technologies including Sciex Triple Quad 7500+, MSD Quickplex 120, Cytek Aurora, BD FACSymphony A3 and digital PCR platforms. Agilex holds ISO/IEC 17025 accreditation, OECD GLP recognition with NATA, and ISO 27001:2022 certification for information security.With Australia’s largest dedicated bioanalytical team, Agilex partners with sponsors across the US, EU and APAC to deliver flexible, high-quality solutions that accelerate clinical development timelines. Connect with our team at BIO 2026 to explore how Australia can support your next program.

Bioanalytical Services

Focus

Innovation Specialisation

mRNA

Protein

Small Molecule

Contact person(s):

Year founded: 1996

No of Employees: 200-220

Alithia Life Sciences is proudly Australian-owned, full-service CRO partnering with pharmaceutical, biotechnology, medical device companies, and institutional research groups, offering flexible, personalised solutions to deliver high-quality clinical development programs across Australia and globally.

Biome

Cardiovascular

Fibrosis

Focus

Full-service CRO

Gastroenterology

Infectious diseases & global health

Innovation Specialisation

Medical Device

mRNA

Neurosience (inc CNS)

Oncology

Opthamology

Pain

Protein

Rare diseases

Regenerative Medicine

Small Molecule

Therapeutic-Indication Specialisation

Vaccines

Women's health

Contact person(s):

Languages: EnglishGreekSerbianBosnianFrenchAzerbaijaniArabicItalian

Year founded: 2021

No of Employees: 15-22

Avion Full-Service CRO & Research Imaging Specialists Avion is a leading full-service CRO & research imaging specialist partner for clinical trials and medical research delivering end-to-end clinical trial solutions. With expertise in Oncology, Nuclear Medicine & Theranostics, Research Imaging, Dermatology, Nutrition and more, we partner with pharmaceutical, biotech, and medical device companies to ensure successful completion of trials in all stages of development. Headquartered in Melbourne, Avion fully understand the highly favourable research environment that Australia provides and also work globally with far reaching capabilities and experience. Our team’s commitment to quality and innovation ensures seamless execution of complex clinical studies, providing tailored solutions to meet the unique needs of each trial, optimising outcomes and accelerating the development of life-changing treatments. We specialise in early phase clinical trials and understand how critical and complex early-stage clinical development is. By leveraging decades of research experience and an unparalleled working relationship with industry and clinicians, we provide a solution that is driven by the latest knowledge to deliver on company needs. We also possess niche expertise in the clinical development of radiopharmaceuticals to ensure successful completion of theranostic projects.

Cardiovascular

Clinical/ Specialist CRO Services

Focus

Full-service CRO

Gastroenterology

Haematology

Immunology

Innovation Specialisation

Internal medicine

Medical Device

Metabolic

Nephrology

Neurosience (inc CNS)

Obesity, growth disorders

Oncology

Opthamology

Protein

Rare diseases

Regenerative Medicine

Respiratory

Services

Small Molecule

Therapeutic-Indication Specialisation

Contact person(s):

Year founded: 2018

No of Employees: 20-25

Bentleys is an international network of advisory and accounting firms that assists aspirational and entrepreneurial businesses in achieving their goals.Our advisory, accounting, audit and taxation services are strengthened by our expanding range of specialisations, enabling us to support the broad needs of individuals and enterprises at every stage of the business lifecycle. In addition to business advisory, accounting, audit and taxation services, our specialisations include; R&D tax incentives and government funding services and advice; business advancement advice; financial planning and wealth management including self-managed super funds; international taxation consulting; business and residential finance and corporate recovery services. Our recent rise through the ranks of the Australian Financial Reviews Top 100 Accounting Firms is evident we are a contemporary firm, thinking ahead for our clients.Bentleys is a member of Allinial Global, an association of independent accounting and consulting firms across the world. With our local expertise, national presence and international capability, we work with enterprises at every stage of their business journey to help them prepare for tomorrow.Bentleys is a network of independent advisory and accounting firms located throughout Australia, New Zealand and China that trade as Bentleys. All members of the Bentleys Network are affiliated only and are separate legal entities and not in partnership. Liability limited by a scheme approved under Professional Standards Legislation.

Focus

R&D Tax Incentive

Contact person(s):

Year founded: 1975

No of Employees: 650-700

Clinials is a Protocol Intelligence Platform that generates the complete clinical trial startup document suite from a single protocol upload. Built for sponsors, CROs, site networks, central labs, and logistics suppliers, Clinials compresses weeks of manual document preparation into minutes.From one protocol upload, Clinials generates: Schedule of Activities, Informed Consent Forms, Source case report forms, plain language summaries, patient recruitment materials, operational protocol synopsis, investigator summaries, lab listings, CIR's and Protocol to Marketing reports.Clinials operates on AWS infrastructure with SOC 2, ISO 27001, and AES-256 encryption. Outputs are aligned with EU CTR 536, ICH E6(R3), ICH E17, and FDA 2025 plain language guidance.Clinials serves sponsors, CROs, site networks, SMOs, IROs, central labs, and clinical trial logistics suppliers across North America, Europe, Asia Pacific, and the United Kingdom. No integration with existing eClinical systems is required.

Focus

Innovation Specialisation

Services

Contact person(s):

Year founded: 2021

No of Employees: 5-10

Global R&D is a dedicated R&D Tax Incentive consultancy with a truly global reach. We provide valuable, expert guidance on all aspects of R&D Tax matters to companies across Australia, China, EU, Singapore, South Korea, and the USA.Working actively across the start-up and SME community, Global R&D provides R&D Tax Advisory services across the various Tech sectors, including but not limited to AgriTech, BioTech, FinTech, Life Sciences, MedTech, Manufacturing, Mining and Pharma.In addition to providing insightful and expert advice, trusted guidance, and focused resources to ensure compliant R&D Tax Incentive claims, Global R&D has already enabled clients to receive cash refunds that exceed client expectations.We pride ourselves in providing significant pro bono time and effort to various incubators, accelerators and their founder/techpreneur communities.Founder and Director, Dr Pavel Reddy comes with 18+ years of R&D Tax expertise, having worked for a Big Four firm, as well as another local respected R&D Tax advisory firm. With a Doctorate in Biology and a 20-year academic career in the Sciences, Pavel is well-placed to identify and understand the technology that underpins R&D Tax Incentive claims across several sectors.Pavel has also met the requirements for R&D Tax Agent registration and is currently registered with the Australian Government’s Tax Practitioners Board.Global R&D is in regular contact with the regulatory bodies, the Australian Taxation Office and AusIndustry. This enables the business to keep abreast with relevant information relating to the R&D Tax Incentive program, which is shared with our clients.

Focus

R&D Tax Incentive

Contact person(s):

Languages: EnglishAfrikaans

Year founded: 2022

No of Employees: 1-5

Linear Clinical Research provides the most comprehensive clinical trial site capability in Australia, delivered across three specialist facilities, including the purpose-built Joondalup Early Phase Centre and Australia's first private hospital dedicated to cancer and other therapeutic trials, the Advanced Clinical Trial Centre.Leveraging rapid trial start-up and eSource technology, Linear delivers trials across all phases in healthy volunteers and patient groups, including next generation molecules such as RNA, bi/trispecifics and cell therapy. Having delivered over 500 trials since opening in 2010, Linear has developed innovative practices across volunteer recruitment, data capture, quality assurance and medical governance.As a profit-for-purpose company and subsidiary of the Harry Perkins Institute of Medical Research, Linear is solely invested in the success of your clinical program. We hold dedicated Medical Directors across our core portfolios of Phase I healthy volunteer, oncology, haematology, immunology and cardiometabolic, with capability extending across a broad range of therapeutic areas, enabling critical protocol optimisation and medical recommendations tailored to your programme.Australia offers a uniquely compelling environment for early-phase development. A fast regulatory framework removes the need for an IND application, an experienced and drug-naive volunteer population supports clean, high-quality data, and eligible pre-revenue biotechs benefit from a 43.5% R&D cashback incentive, making Australia one of the most cost-competitive destinations for first-in-human research globally.

Cardiovascular

Focus

Gastroenterology

Haematology

Immunology

Infectious diseases & global health

Metabolic

Nephrology

Obesity, growth disorders

Oncology

Pain

Phase 1 Site

Rare diseases

Therapeutic-Indication Specialisation

Vaccines

Working with:

Contact person(s):

Year founded: 2010

No of Employees: 260-300

Nucleus Network is Australia’s largest and only multi-site Phase 1 clinical research organisation and the only Clinical Pharmacology specialist globally with facilities in Australia, the USA, and the UK.For over two decades, Nucleus Network has been conducting Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe, including the USA, China, Europe, Japan, South Korea, and Taiwan.Recognized as Phase 1 clinical trial experts, we operate over 200 beds, and have overseen more than 1,500 trials, of which 50% are first-in-human.In addition to FIH program, our extensive experience also includes the conduct of DDI, FE, Vaccine, Biosimilar, Renal Impairment, and ethnobridging studies.Our Australian Phase 1 facilities are in Melbourne, Brisbane, and Sydney. Our clinical unit in the USA is in Minneapolis, and our UK unit is in London.All five clinics are strategically co-located within leading medical, research and biotech precincts; the Alfred Hospital in Melbourne, the Royal Brisbane and Women’s Hospital in Brisbane, the Royal North Shore Hospital in Sydney, Medical Alley in Minneapolis, and Central Middlesex Hospital in London.

Focus

Phase 1 Site

Working with:

Contact person(s):

Year founded: 2002

No of Employees: 650-700

PharmSky is an integrated CDMO, based in Melbourne Australia. We provide integrated CMC development, from API and drug product development through to the manufacture and supply of clinical trial materials, supporting clinical‐stage companies Our capabilities span multiple dosage forms, including sterile products, liquid and solid orals, with deep expertise in complex drugs such as liposomes and nanotechnology‐based formulations. Our facilities are built on ex‐Pfizer R&D operations, bringing years of hands‐on development experience. Eligible work may also qualify for Australia’s 43.5% R&D tax incentive.

Aesthetics

Bone health

Cardiovascular

CDMO

Consumer healthcare

Fibrosis

Focus

Gastroenterology

Haematology

Immunology

Infectious diseases & global health

Innovation Specialisation

Internal medicine

Metabolic

Nephrology

Neurosience (inc CNS)

Obesity, growth disorders

Oncology

Opthamology

Pain

Plasma derived therapies

Protein

Rare diseases

Regenerative Medicine

Respiratory

Small Molecule

Therapeutic-Indication Specialisation

Women's health

Contact person(s):

No of Employees: 25-30

View all Companies

Showing 1-10 of 11 results